{"article":{"annotation":{"article_id":"australia-respiratory-surveillance-influenza-positivity-october-2026","available_at":"2026-10-13T02:11:48.159395Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"6b5aa4f6eed721250992144628a7502cbf4c4c9a68006b8a5867c1318dface5a","input_sha256":"639992517c9a29ea8f5590009afc5fca16c4c8042139124e08eaa52f018dff6e","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"AU","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.cdc.gov.au/sites/default/files/2026-10/australian_respiratory_surveillance_report_21_september_to_4_october_2026.pdf"]}],"geometry":null,"id":"iso3166-1:AU","kind":"country-or-area","labels":{"ar":"أستراليا","en":"Australia","es":"Australia","fr":"Australie"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:20000448","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: influenza","source_urls":["https://www.cdc.gov.au/sites/default/files/2026-10/australian_respiratory_surveillance_report_21_september_to_4_october_2026.pdf"]}],"method":"controlled-rules-v1","rule_id":"communicable-disease","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/australia-respiratory-surveillance-influenza-positivity-october-2026?lang=ar","category":"health","content":{"key_points":[],"paragraphs":["أفاد المركز الأسترالي لمكافحة الأمراض بإشارات متباينة لفيروسات الجهاز التنفسي خلال الفترة من 21 سبتمبر إلى 4 أكتوبر. انخفضت بلاغات الإنفلونزا 3.0% مقارنة بالأسبوعين السابقين، وتراجعت بلاغات كوفيد-19 بنسبة 15.7% وRSV بنسبة 35.8%. لكن إيجابية PCR للإنفلونزا المبلغ عنها ذاتياً في المسوح المجتمعية بلغت 47.0%، وإيجابية الاختبار السريع للمستضد 41.3%، وكلتاهما أعلى من الفترة السابقة.","يقول التقرير إن الوقت مبكر لتحديد ما إذا كان الانخفاض الوطني المستمر في الإنفلونزا قد بدأ، إذ ظلت بعض الولايات والأقاليم تسجل زيادات. ونسب الاختبارات في المسوح تخص المشاركين الذين أبلغوا عن الحمى والسعال وأجروا اختباراً؛ ولا تمثل معدلات العدوى بين السكان. بيانات الترصد أولية وقد تتغير، كما يشير التقرير إلى نقص بعض البلاغات الحديثة من أقاليم محددة."],"sections":[]},"corrections":[],"country":"AU","data":{"blocks":[{"columns":[{"key":"indicator","label":{"ar":"المؤشر","de":"Indikator","en":"Indicator","es":"Indicador","fr":"Indicateur","pt":"Indicador","tr":"Gösterge"},"language":"en","type":"text"},{"key":"value","label":{"ar":"إيجابية الاختبار","de":"Testpositivität","en":"Test positivity","es":"Positividad de la prueba","fr":"Positivité du test","pt":"Positividade do teste","tr":"Test pozitifliği"},"type":"number","unit":"percent"},{"key":"study_scope","label":{"ar":"النطاق والطريقة","de":"Umfang und Methode","en":"Scope and method","es":"Alcance y método","fr":"Périmètre et méthode","pt":"Âmbito e método","tr":"Kapsam ve yöntem"},"language":"en","type":"text"}],"description":{"ar":"النسب تخص المشاركين في المسح المجتمعي الذين أبلغوا عن أعراض واختبار؛ وليست معدلات حالات وطنية.","de":"Prozentwerte der Umfrageteilnehmenden mit gemeldeten Symptomen und Test; keine nationalen Fallraten.","en":"Percentages are for community-survey participants reporting symptoms and a test; they are not national case rates.","es":"Porcentajes de participantes de encuestas que declararon síntomas y una prueba; no son tasas nacionales de casos.","fr":"Pourcentages parmi les participants à l’enquête ayant déclaré des symptômes et un test; ce ne sont pas des taux nationaux de cas.","pt":"Percentagens de participantes no inquérito que relataram sintomas e teste; não são taxas nacionais de casos.","tr":"Yüzdeler toplum anketine katılan ve belirtilerle birlikte test bildiren kişiler içindir; ulusal vaka oranı değildir."},"id":"source-measurements","methodology":{"ar":"القيم كما أوردها التقرير الأسترالي للفترة 21 سبتمبر–4 أكتوبر 2026. ويذكر التقرير أن الترصد أولي وقابل للمراجعة؛ وتعتمد نسب الاختبارات على الإبلاغ الذاتي.","de":"Angaben des australischen Berichts für den Zeitraum 21. September bis 4. Oktober 2026. Der Bericht weist auf vorläufige, revidierbare Überwachungsdaten hin; Testprozente beruhen auf Selbstangaben.","en":"Figures are those reported by the Australian report for 21 September–4 October 2026. The report states surveillance is preliminary and may be revised; test percentages rely on self-report.","es":"Valores del informe australiano para el período del 21 de septiembre al 4 de octubre de 2026. El informe indica que la vigilancia es preliminar y revisable; los porcentajes de pruebas se basan en autodeclaraciones.","fr":"Valeurs du rapport australien pour la période du 21 septembre au 4 octobre 2026. Le rapport précise que la surveillance est préliminaire et peut être révisée; les pourcentages reposent sur des déclarations individuelles.","pt":"Valores do relatório australiano para 21 de setembro a 4 de outubro de 2026. O relatório afirma que os dados de vigilância são preliminares e podem ser revistos; as percentagens baseiam-se em autorrelato.","tr":"Rakamlar, Avustralya raporunun 21 Eylül–4 Ekim 2026 dönemi için bildirdiği değerlerdir. Raporda gözetim verilerinin ön nitelikte olduğu ve değişebileceği belirtilir; test pozitifliği yüzdeleri kişilerin kendi bildirimlerine dayanır."},"rowTranslations":[{"indicator":{"ar":"إيجابية PCR للإنفلونزا المبلغ عنها ذاتياً","de":"Selbstberichtete Influenza-PCR-Positivität","en":"Self-reported influenza PCR positivity","es":"Positividad autodeclarada de PCR para gripe","fr":"Positivité déclarée des PCR de grippe","pt":"Positividade autodeclarada de PCR para gripe","tr":"Kendi bildirimli influenza PCR pozitifliği"},"study_scope":{"ar":"مشاركو المسح المجتمعي الذين أبلغوا عن الحمى والسعال وأجروا اختبار PCR؛ لا تمثل معدل عدوى السكان.","de":"Umfrageteilnehmende mit gemeldetem Fieber und Husten, die einen PCR-Test angaben; keine Infektionsrate der Bevölkerung.","en":"Community-survey participants reporting fever and cough who reported having a PCR test; not a population infection rate.","es":"Participantes de la encuesta con fiebre y tos que declararon haberse hecho PCR; no es una tasa de infección poblacional.","fr":"Participants à l’enquête ayant déclaré fièvre et toux et avoir passé une PCR; ne représente pas un taux d’infection de la population.","pt":"Participantes no inquérito que relataram febre e tosse e terem feito PCR; não representa taxa de infeção populacional.","tr":"Ateş ve öksürük bildiren ve PCR testi yaptırdığını bildiren toplum anketi katılımcıları; nüfus enfeksiyon oranı değildir."}},{"indicator":{"ar":"إيجابية اختبار المستضد السريع للإنفلونزا المبلغ عنها ذاتياً","de":"Selbstberichtete Positivität von Influenza-Antigen-Schnelltests","en":"Self-reported influenza rapid antigen test positivity","es":"Positividad autodeclarada de pruebas rápidas de antígenos para gripe","fr":"Positivité déclarée des tests antigéniques rapides de grippe","pt":"Positividade autodeclarada de testes rápidos de antigénio da gripe","tr":"Kendi bildirimli influenza hızlı antijen testi pozitifliği"},"study_scope":{"ar":"مشاركو المسح المجتمعي الذين أبلغوا عن الحمى والسعال وأجروا اختباراً سريعاً؛ لا تمثل معدل عدوى السكان.","de":"Umfrageteilnehmende mit gemeldetem Fieber und Husten, die einen Schnelltest angaben; keine Infektionsrate der Bevölkerung.","en":"Community-survey participants reporting fever and cough who reported having a rapid test; not a population infection rate.","es":"Participantes de la encuesta con fiebre y tos que declararon haberse hecho una prueba rápida; no es una tasa de infección poblacional.","fr":"Participants à l’enquête ayant déclaré fièvre et toux et avoir passé un test rapide; ne représente pas un taux d’infection de la population.","pt":"Participantes no inquérito que relataram febre e tosse e terem feito teste rápido; não representa taxa de infeção populacional.","tr":"Ateş ve öksürük bildiren ve hızlı test yaptırdığını bildiren toplum anketi katılımcıları; nüfus enfeksiyon oranı değildir."}}],"rows":[{"indicator":"Self-reported influenza PCR positivity","study_scope":"Community-survey participants reporting fever and cough who reported having a PCR test; not a population infection rate.","value":47.0},{"indicator":"Self-reported influenza rapid antigen test positivity","study_scope":"Community-survey participants reporting fever and cough who reported having a rapid test; not a population infection rate.","value":41.3}],"sourceUrls":["https://www.cdc.gov.au/sites/default/files/2026-10/australian_respiratory_surveillance_report_21_september_to_4_october_2026.pdf"],"title":{"ar":"إيجابية اختبارات الإنفلونزا في المسوح المجتمعية","de":"Influenza-Testpositivität in Bevölkerungsumfragen","en":"Influenza test positivity in community surveys","es":"Positividad de pruebas de gripe en encuestas comunitarias","fr":"Positivité des tests de grippe dans les enquêtes communautaires","pt":"Positividade de testes de gripe em inquéritos comunitários","tr":"Toplum anketlerinde influenza testi pozitifliği"},"type":"table","updatedAt":"2026-10-13T02:07:49Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/australia-respiratory-surveillance-influenza-positivity-october-2026/data/source-measurements?lang=ar&format=csv","json":"https://newsverum.com/api/v1/articles/australia-respiratory-surveillance-influenza-positivity-october-2026/data/source-measurements?lang=ar&format=json"},"id":"source-measurements"}],"data_types":["table"],"editorial_illustration":{"alt":"رسم توضيحي مفاهيمي للصحة العامة والبحث والبيانات المترابطة.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"ar","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-886a5569-ef0d-5702-a34d-5a736583cb54","event_period":"2026-10-04","event_period_basis":"source-review","id":"australia-respiratory-surveillance-influenza-positivity-october-2026","image":null,"importance":0.6,"language":"ar","modified_at":"2026-10-13T02:11:42+00:00","publication_basis":"publication-record","published_at":"2026-10-13T02:11:42+00:00","reading_minutes":1,"region":"world","relations":[],"section_illustration":{"alt":"رسم توضيحي مفاهيمي للصحة العامة والبحث والبيانات المترابطة.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"ar","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"australia-respiratory-surveillance-influenza-positivity-october-2026","sources":[{"checkedAt":"2026-10-13","name":"Australian Centre for Disease Control","publishedAt":"2026-10-09","url":"https://www.cdc.gov.au/sites/default/files/2026-10/australian_respiratory_surveillance_report_21_september_to_4_october_2026.pdf"}],"summary":"بين 21 سبتمبر و4 أكتوبر، انخفضت بلاغات الإنفلونزا قليلاً، بينما ارتفعت إيجابية اختبارات PCR والاختبارات السريعة للإنفلونزا المبلغ عنها ذاتياً في المسوح المجتمعية إلى 47.0% و41.3%؛ والبيانات أولية.","text":"بين 21 سبتمبر و4 أكتوبر، انخفضت بلاغات الإنفلونزا قليلاً، بينما ارتفعت إيجابية اختبارات PCR والاختبارات السريعة للإنفلونزا المبلغ عنها ذاتياً في المسوح المجتمعية إلى 47.0% و41.3%؛ والبيانات أولية.\n\nأفاد المركز الأسترالي لمكافحة الأمراض بإشارات متباينة لفيروسات الجهاز التنفسي خلال الفترة من 21 سبتمبر إلى 4 أكتوبر. انخفضت بلاغات الإنفلونزا 3.0% مقارنة بالأسبوعين السابقين، وتراجعت بلاغات كوفيد-19 بنسبة 15.7% وRSV بنسبة 35.8%. لكن إيجابية PCR للإنفلونزا المبلغ عنها ذاتياً في المسوح المجتمعية بلغت 47.0%، وإيجابية الاختبار السريع للمستضد 41.3%، وكلتاهما أعلى من الفترة السابقة.\n\nيقول التقرير إن الوقت مبكر لتحديد ما إذا كان الانخفاض الوطني المستمر في الإنفلونزا قد بدأ، إذ ظلت بعض الولايات والأقاليم تسجل زيادات. ونسب الاختبارات في المسوح تخص المشاركين الذين أبلغوا عن الحمى والسعال وأجروا اختباراً؛ ولا تمثل معدلات العدوى بين السكان. بيانات الترصد أولية وقد تتغير، كما يشير التقرير إلى نقص بعض البلاغات الحديثة من أقاليم محددة.","title":"تقرير أسترالي يرصد ارتفاع إيجابية اختبارات الإنفلونزا مع تراجع بلاغات كوفيد-19 وRSV","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/australia-respiratory-surveillance-influenza-positivity-october-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/australia-respiratory-surveillance-influenza-positivity-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/australia-respiratory-surveillance-influenza-positivity-october-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/australia-respiratory-surveillance-influenza-positivity-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/australia-respiratory-surveillance-influenza-positivity-october-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/australia-respiratory-surveillance-influenza-positivity-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/australia-respiratory-surveillance-influenza-positivity-october-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/australia-respiratory-surveillance-influenza-positivity-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/australia-respiratory-surveillance-influenza-positivity-october-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/australia-respiratory-surveillance-influenza-positivity-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/australia-respiratory-surveillance-influenza-positivity-october-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/australia-respiratory-surveillance-influenza-positivity-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/australia-respiratory-surveillance-influenza-positivity-october-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/australia-respiratory-surveillance-influenza-positivity-october-2026"}],"url":"https://newsverum.com/ar/news/australia-respiratory-surveillance-influenza-positivity-october-2026"},"version":"1"}